Content area

|
|

Laparoskopisk intraperitoneal kemoterapi under tryk (PIPAC) til behandling af peritoneale metastaser

Forfatter(e)
Martin Graversen1, 2, Sönke Detlefsen1, 3, Signe Bremholm Ellebæk1, 2, Anja Ør Knudsen1, 4, Per Pfeiffer1, 4 & Michael Bau Mortensen1, 2
1) Odense PIPAC Center2) Kirurgisk Afdeling, Odense Universitetshospital3) Afdeling for Klinisk Patologi, Odense Universitetshospital4) Onkologisk Afdeling, Odense Universitetshospital

Ugeskr Læger 2019;181:V04190224
Reference: 
Ugeskr Læger 2019;181:V04190224
Blad nummer: 

Martin Graversen, Sönke Detlefsen, Anja Ør Knudsen, Per Pfeiffer &
Michael Bau Mortensen:

Pressurised intraperitoneal aerosol chemotherapy (PIPAC) for the
treatment of peritoneal metastases

Ugeskr Læger 2019;181:V04190224

Pressurised intraperitoneal aerosol chemotherapy (PIPAC) was introduced in Denmark in 2015. More than 100 Danish patients with peritoneal metastases (PM) have received PIPAC-directed treatment within the PIPAC-OPC1 and PIPAC-OPC2 trials. PIPAC-directed treatment is feasible and safe, and there are no occupational risks for the involved healthcare professionals. An objective tumour response is seen in two out of three patients, and the survival data warrant further evaluation in large-scale randomised trials in patients with PM from different primary tumours.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Marianne Puge Nielsen | 13/11
1 Kommentar
af Akil Raad Kami Abdel-Wahab Walli | 13/11
6 kommentarer
af Larry Højgaard Kristiansen | 11/11
1 Kommentar
af Sven Refslund Poulsen | 09/11
3 kommentarer
af Christian Crüger | 06/11
1 Kommentar
af Anders Christiansen | 05/11
1 Kommentar
af Thamilini Umaramanan | 05/11
2 kommentarer